Potential Molecular Mechanism of Bajitian – Niuxi Formula Delays Intervertebral Disc Degeneration: An Animal Experiment and Network Pharmacology
Chemistry & Biodiversity · 09.04.2025
DOI: 10.1002/cbdv.202500048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 09.04.2025. Verfasst von Yilong Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, ZhongNan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, Network Pharmacology, Drugs, Chinese Herbal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: Key Research and Development Program of Hubei Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Intervertebral disc degeneration (IDD) continues to be a major health concern. The combination of Bajitian and Niuxi (B&N) is commonly used to treat musculoskeletal degenerative diseases. This study aimed to explore the potential of B&N in treating IDD through in vivo experiments and bioinformatics approaches. In vivo experiments found that the process of IDD in rats treated with B&N extracts was delayed. Through database screening and network pharmacology analysis, it was discovered that multiple key drug‐active ingredients (DAIs) of B&N, such as wogonin, baicalein, 1‐hydroxy‐3‐methoxy‐9,10‐anthraquinone, and beta‐sitosterol, might play a role in the treatment of IDD, among which signaling pathways, such as PI3K–AKT, MAPK, and senescence signaling, might be the main drug‐regulated pathways. The binding potential and position of the main DAIs to the core targets were verified by structural bioinformatics. Immunohistochemistry and qRT‐PCR results indicated that B&N treatment could improve the expressions of Type II collagen (Col‐2) and aggrecan (ACAN) in IDD rats, which might be related to the phosphorylation levels of AKT and p38. Therefore, the B&N formula might delay IDD in rats by regulating multiple signaling pathways through DAIs, which provides new approaches for further exploring the prevention and treatment strategies of IDD with traditional Chinese medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, ZhongNan Hospital of Wuhan University, Wuhan, China.
- College of Life Sciences, Wuhan University, Wuhan, China.
- Department of Orthopedics, Taizhou People's Hospital Affiliated with Nanjing Medical University, Taizhou, China.
- Department of Orthopedics, Yangxin People's Hospital, Huangshi, China.
ORCID-Profile: Jingfeng Li
Förderung
- Key Research and Development Program of Hubei Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Huang, Y., Zhang, Q., Wang, J., Luan, T., Guo, L., Hao, Z., Shi, G., Chen, R., Wu, Z., Zhou, X., Zhou, S., Shen, Q., & Li, J. (2025). Potential Molecular Mechanism of Bajitian – Niuxi Formula Delays Intervertebral Disc Degeneration: An Animal Experiment and Network Pharmacology. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500048
Vancouver
Huang Y, Zhang Q, Wang J, Luan T, Guo L, Hao Z, et al. Potential Molecular Mechanism of Bajitian – Niuxi Formula Delays Intervertebral Disc Degeneration: An Animal Experiment and Network Pharmacology. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500048
BibTeX
@article{Huang2025,
author = {Huang, Yilong and Zhang, Qi and Wang, Junwu and Luan, Tian and Guo, Lanhong and Hao, Zhuowen and Shi, Guang and Chen, Renxin and Wu, Zijian and Zhou, Xuan'ang and Zhou, Shifeng and Shen, Qixiao and Li, Jingfeng},
title = {Potential Molecular Mechanism of Bajitian – Niuxi Formula Delays Intervertebral Disc Degeneration: An Animal Experiment and Network Pharmacology},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202500048}
}
EUVIMED